Literature DB >> 2569346

Mode of antinociceptive action of flupirtine in the rat.

I Szelenyi1, B Nickel, H O Borbe, K Brune.   

Abstract

1. Flupirtine is a novel, centrally acting, non-opioid analgesic agent. The present investigation was undertaken to ascertain which neuronal systems might be responsible for its antinociceptive effect in rodents. The antinociceptive responses to the test compounds were examined in the tail-flick test. 2. The selective destruction of noradrenergic pathways by 6-hydroxydopamine considerably reduced the flupirtine-induced inhibition of nociceptive responses but not the clonidine-induced antinociception which was significantly enhanced. Depletion of spinal 5-hydroxytryptaminergic pathways by pretreatment with 5,7-dihydroxytryptamine failed to affect the action of flupirtine and clonidine. 3. The depletion of neurotransmitters by reserpine totally abolished the antinociceptive action of flupirtine. By contrast, clonidine-induced inhibition of nociceptive responses remained unchanged. 4. Inhibition of the synthesis of noradrenaline by alpha-methyl-L-p-tyrosine attenuated the antinociception induced by flupirtine. In contrast, inhibition of the synthesis of 5-hydroxytryptamine by (+/-)-6-fluorotryptophan did not influence the antinociceptive activity of flupirtine. 5. Inhibition of noradrenaline uptake by imipramine led to a significant augmentation of flupirtine-induced antinociception. 6. Selective antagonists at alpha-adrenoceptors significantly decreased the antinociceptive action of flupirtine. Antinociception induced by clonidine was significantly diminished by idazoxan but not by prazosin. 7. The 5-hydroxytryptamine (5-HT) antagonist, ketanserin diminished the antinociceptive activity of flupirtine, probably due to its additional alpha 1-adrenoceptor antagonist activity. The antinociceptive effect of clonidine was not influenced by ketanserin. 8. Cholinoceptor antagonists such as mecamylamine and pirenzepine did not alter the antinociceptive action of flupirtine. Flupirtine-induced antinociception also remained unchanged after pretreatment with haloperidol. 9. Flupirtine has no pharmacologically relevant affinity for alpha 1-, alpha 2-adrenoceptors, 5-HT1- and 5-HT2-receptors as shown in direct binding studies. 10. The present results indicate that the antinociceptive action induced by flupirtine depends on the descending noradrenergic pain-modulating system.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2569346      PMCID: PMC1854566          DOI: 10.1111/j.1476-5381.1989.tb12023.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  25 in total

1.  Noradrenergic-serotonergic interactions and nociception in the rat.

Authors:  T Archer; G Jonsson; B G Minor; C Post
Journal:  Eur J Pharmacol       Date:  1986-01-29       Impact factor: 4.432

2.  Action of peptides and other algesic agents on paravascular pain receptors of the isolated perfused rabbit ear.

Authors:  H Juan; F Lembeck
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

3.  Noradrenergic and serotonergic mediation of spinal analgesia mechanisms.

Authors:  F P Zemlan; S A Corrigan; D W Pfaff
Journal:  Eur J Pharmacol       Date:  1980-01-25       Impact factor: 4.432

4.  Alpha-adrenoceptor-mediated antinociception and sedation in the rat and dog.

Authors:  A G Hayes; M Skingle; M B Tyers
Journal:  Neuropharmacology       Date:  1986-04       Impact factor: 5.250

5.  [Mechanism of action of the analgesic flupirtine].

Authors:  B Nickel; A Herz; V Jakovlev; U Tibes
Journal:  Arzneimittelforschung       Date:  1985

6.  Changes in sensitivity to intrathecal norepinephrine and serotonin after 6-hydroxydopamine (6-OHDA), 5,6-dihydroxytryptamine (5,6-DHT) or repeated monoamine administration.

Authors:  J R Howe; T L Yaksh
Journal:  J Pharmacol Exp Ther       Date:  1982-02       Impact factor: 4.030

7.  Different antagonistic effects of bunazosin and ketanserin on the norepinephrine-induced vasoconstriction in isolated, perfused canine and simian skeletal muscle arteries.

Authors:  O Sinanović; S Chiba
Journal:  Jpn J Pharmacol       Date:  1988-02

8.  Reversal by serotonergic agents of reserpine-induced hyperalgesia in rats.

Authors:  S K Kulkarni; R K Robert
Journal:  Eur J Pharmacol       Date:  1982-09-24       Impact factor: 4.432

9.  Reserpine and sympathetic denervation cause an increase of postsynaptic alpha 2-adrenoceptors.

Authors:  Y Watanabe; R T Lai; H Maeda; H Yoshida
Journal:  Eur J Pharmacol       Date:  1982-05-07       Impact factor: 4.432

10.  Amitriptylinoxide: receptor-binding profile compared with other antidepressant drugs.

Authors:  H O Borbe; O Zierenberg
Journal:  Pharmacopsychiatry       Date:  1985-09       Impact factor: 5.788

View more
  11 in total

Review 1.  KCNQ potassium channels in sensory system and neural circuits.

Authors:  Jing-jing Wang; Yang Li
Journal:  Acta Pharmacol Sin       Date:  2015-12-21       Impact factor: 6.150

Review 2.  Flupirtine in pain management: pharmacological properties and clinical use.

Authors:  Jacques Devulder
Journal:  CNS Drugs       Date:  2010-10       Impact factor: 5.749

Review 3.  Flupirtine, a re-discovered drug, revisited.

Authors:  Istvan Szelenyi
Journal:  Inflamm Res       Date:  2013-01-16       Impact factor: 4.575

Review 4.  Flupirtine. A review of its pharmacological properties, and therapeutic efficacy in pain states.

Authors:  H A Friedel; A Fitton
Journal:  Drugs       Date:  1993-04       Impact factor: 9.546

5.  Dose-related analgesic effects of flupirtine.

Authors:  T Hummel; T Friedmann; E Pauli; G Niebch; H O Borbe; G Kobal
Journal:  Br J Clin Pharmacol       Date:  1991-07       Impact factor: 4.335

6.  Influence of flupirtine, a novel nonopioid analgesic agent on somatosensory evoked potentials in rats.

Authors:  L Nagymajtenyi; B Nickel; I Desi; I Szelenyi
Journal:  Experientia       Date:  1992-10-15

7.  Treatment with the Kv7 potassium channel activator flupirtine is beneficial in two independent mouse models of pulmonary hypertension.

Authors:  I Morecroft; A Murray; M Nilsen; A M Gurney; M R MacLean
Journal:  Br J Pharmacol       Date:  2009-06-05       Impact factor: 8.739

8.  Transcriptional repression of the M channel subunit Kv7.2 in chronic nerve injury.

Authors:  Kirstin Rose; Lezanne Ooi; Carine Dalle; Brian Robertson; Ian C Wood; Nikita Gamper
Journal:  Pain       Date:  2011-02-23       Impact factor: 7.926

Review 9.  Chemical modulation of Kv7 potassium channels.

Authors:  Matteo Borgini; Pravat Mondal; Ruiting Liu; Peter Wipf
Journal:  RSC Med Chem       Date:  2021-01-14

10.  Role of flupirtine as a preemptive analgesic in patients undergoing laparoscopic cholecystectomy.

Authors:  Ghanshyam Yadav; Shailaja Shankar Behera; Saurabh Kumar Das; Gaurav Jain; Sujali Choupoo; Janak Raj
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2015 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.